Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

AML-348 A Phase Ib/II Study of Ivosidenib With Venetoclax +/- Azacitidine in IDH1-Mutated Hematologic Malignancies

Journal article

Lachowiez C. et al, (2022), Clinical Lymphoma, Myeloma and Leukemia, 22, S240 - S241

How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines?

Journal article

Cowie MR. et al, (2022), International journal of cardiology, 365, 61 - 68

miR-3156-5p is downregulated in serum of MEN1 patients and regulates expression of MORF4L2.

Journal article

Kooblall KG. et al, (2022), Endocr Relat Cancer, 29, 557 - 568

On the open-source landscape of Magnetic Resonance in Medicine

Journal article

Boudreau M. et al, (2022), Magnetic Resonance in Medicine, 88, 1495 - 1497

Homoarginine and creatine deficiency do not exacerbate murine ischaemic heart failure

Journal article

McAndrew DJ. et al, (2022), ESC Heart Failure

Load More